Announcements Trials
Browse Landscape

Phase

Phase NA 23Phase 2/3 6Phase 1/2 6Phase 2 4Phase 1 3Phase EARLY_PHASE1 1Phase 3 1

Status

Completed 6Unknown 4Withdrawn 1Not yet recruiting 1

Sponsor Class

OTHER 6

Study Type

Interventional 6

Sponsor

Cancer Type

Gastrointestinal 5Thoracic 1

Conditions

Pancreatic Neoplasms 3Lung Neoplasms 1Liver Neoplasms 1Carcinoma, Hepatocellular 1

Interventions

Cyclophosphamide 142Gemcitabine 129Paclitaxel 125Radiotherapy 119Carboplatin 112Cisplatin 111pembrolizumab 110Nivolumab 106Docetaxel 90Rituximab 86Lenalidomide 77Dexamethasone 76Cytarabine 69Bevacizumab 64Fluorouracil 63Etoposide 63Oxaliplatin 62Filgrastim 59Peripheral Blood Stem Cell Transplantation 58Everolimus 58Capecitabine 58fludarabine phosphate 57Doxorubicin 56Temozolomide 55Prednisone 54Irinotecan 53Cetuximab 50fludarabine 48Ipilimumab 48Erlotinib Hydrochloride 48

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Phase 1/2 × Completed × Electroporation × Clear all
NCT01939665 2022-12-20

PANFIRE

Amsterdam UMC, location VUmc

Phase 1/2 Completed
50 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT03180437 2020-11-02

Safety and Efficiency of IRE Plus γδ T Cell Against Locally Advanced Pancreatic Cancer

Fuda Cancer Hospital, Guangzhou

Phase 1/2 Completed
62 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT03183219 2020-07-13

Safety and Efficiency of γδ T Cell Against Liver Cancer

Fuda Cancer Hospital, Guangzhou

Phase 1/2 Completed
30 enrolled
Gastrointestinal

Liver Neoplasms

NCT03183232 2020-07-13

Safety and Efficiency of γδ T Cell Against Lung Cancer

Fuda Cancer Hospital, Guangzhou

Phase 1/2 Completed
30 enrolled
Thoracic

Lung Neoplasms

NCT02718859 2019-09-12

Combination of Irreversible Electroporation and NK Immunotherapy for Advanced Pancreatic Cancer

Fuda Cancer Hospital, Guangzhou

Phase 1/2 Completed
60 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT03008343 2019-09-12

Combination of Irreversible Electroporation and NK Immunotherapy for Recurrent Liver Cancer

Fuda Cancer Hospital, Guangzhou

Phase 1/2 Completed
20 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡